{"name":"Proviva Therapeutics, Inc.","slug":"proviva-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNOVVsQ2tSNUY4Z2VraUVSeUJuOTYtU2pVbmR6RGIzWFJ6NF9McE9zeWx6OWMtQ1RVU2ZLaXhDV1VWMXVpb09EN19OZkVnNGdVZ0ZIR3h5bTFtN0Y4TS1Ibk1ESGsyUnNWS2ZXTEhzWXRSUXlaaC1BVENfTUpoYkxLU3VBc2JNTHE1RmVwMXIyektsUDhWTUlZSEtVMDNCUTc5UkNhS0ln?oc=5","date":"2024-04-15","type":"pipeline","source":"BioWorld News","summary":"Proviva’s PTX-912 reduces tumor growth in murine melanoma model - BioWorld News","headline":"Proviva’s PTX-912 reduces tumor growth in murine melanoma model","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}